MedTrace Logo

A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes

NCT01008163 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-02-25

No results posted yet for this study

Summary

The purpose of this trial is to determine the dosage selected and to evaluate the efficacy and safety of YY-351.

Conditions

Interventions

DRUG

YY-351/Placebo

comparison of different dosages of drug

DRUG

YY-351/Placebo

comparison of different dosages of drug

DRUG

YY-351

comparison of different dosages of drug

DRUG

Placebo

comparison of different dosages of drug

Sponsors & Collaborators

  • Yuyu Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Soo Lim, MD,PHD · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01008163 on ClinicalTrials.gov